Rajasthan told the Centre that it has found some spices of popular brands MDH and Everest “unsafe” for consumption after tests, as local and global scrutiny of the brands for alleged contamination intensifies.
Hong Kong in April suspended sales of three spice blends produced by MDH and one by Everest, saying they contained high levels of a cancer-causing pesticide ethylene oxide, triggering scrutiny by regulators in India and other markets.
Singapore also ordered a recall of the Everest mix, and New Zealand, the US and Australia have said they were looking into the issues. Britain has applied extra controls on all spices entering from India, the world’s biggest exporter, producer and consumer of spices.
According to a private letter from a senior health official in Rajasthan, Shubhra Singh, to the Food Safety and Standards Authority of India (FSSAI), the state checked samples of many spices and found a batch of Everest spice mix and two by MDH “unsafe”.
MDH and Everest – two of India’s most popular brands – have said their products are safe for consumption. The companies did not respond to a request for comment on the state’s letter.
State authorities of Gujarat and Haryana, where the MDH and Everest batches were made, “should be asked to take action in the matter without delay”, Singh, who is the additional chief secretary for health, wrote in her letter that is not public but has been seen by Reuters.
The FSSAI and Singh did not respond to requests for comment. While the letter did not detail its findings, Rajasthan state authorities said last week in a statement it had seized 12,000 kg of various spices for alleged contamination, and Singh had written letters informing the Centre and states.
The statements added that Rajasthan collected dozens of samples of spices in May, and found that some contained a “very high level” of pesticide and insecticides.
MDH and Everest spices are among the most popular in India and are also sold in Europe, Asia and North America. India’s domestic market for spices was valued at $10.44 billion in 2022, according to Zion Market Research.
Comments
0 comment